Lieber Institute for Brain Development

What Lieber Institute for Brain Development does

The Lieber Institute for Brain Development (LIBD) is an independent nonprofit 501(c)(3) medical research institute founded in 2011 by philanthropists Steve and Connie Lieber and headquartered on the Johns Hopkins Medical Campus in Baltimore, Maryland. It employs 100+ scientists and operates 48,000 square feet of laboratory space dedicated to translating the genetic and molecular mechanisms of schizophrenia and related developmental brain disorders into clinical advances. Its research spans schizophrenia, depression, bipolar disorder, PTSD, autism, addiction, suicide, and aging-related conditions, with formal translational partnerships including Sheppard Pratt Hospital (70,000 patients/year) and Peking University (900+ subjects in a gene-environment study).

LIBD's core assets are the world's largest postmortem human brain repository dedicated to psychiatric research (nearly 5,000 brains with detailed clinical, demographic, and quality-control metadata), a 1,000+ human cell line repository, and a neuroimaging genetics database covering 3,000+ individuals. Underlying capabilities include single-nucleus RNA sequencing (producing the first-ever human habenula cell atlas), ADARB1 RNA editing analysis, and machine-learning-driven functional MRI analysis (Random Forest Multiple Regression). The institute integrates these capabilities into a genes-to-drugs pipeline combining medicinal chemistry, assay development, and in vivo pharmacology, with 4 candidate therapeutics currently in testing.

The organization's revenue model combines philanthropic donations (one-time gifts, monthly Brain Trust program, stock gifts, donor-advised funds, legacy giving) with research grants and government funding (NIH, National Science Foundation). The go-to-market is community-led: donor cultivation via newsletters (Lieber Notes), podcasts (The Rose Window), events, and storytelling around brain donor families (300+ per year). Outputs are distributed through 200+ peer-reviewed publications in high-impact journals and collaborative research programs with global academic and clinical institutions.

Name

Lieber Institute for Brain Development

Legal name

Lieber Institute for Brain Development

Website

https://libd.org

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

101–250 employees

Short description

The Lieber Institute for Brain Development (LIBD) is an independent nonprofit research institute on the Johns Hopkins Medical Campus that studies the genetic and molecular mechanisms of schizophrenia and related brain disorders. It operates the world's largest postmortem brain repository (~5,000 brains) and an active drug discovery pipeline.

Ownership category

akta.pro rank

Product category

Neuroscience Research

NAICS

Medical Laboratories (621511)

akta.pro primary industry

Neurology & CNS Specialty Pharmaceuticals (HLAIACAC)

akta.pro secondary industries

Neurogenetics & Rare Neurologic Diseases (HLAKAIAO), Neurology & Psychiatry (CNS) Pharmaceuticals (HLAIAAAF)

Keywords

• Neuropsychiatric research
• Postmortem brain research
• Drug discovery pipeline
• Genomic neuroscience
• Imaging genetics

Headquarters

HQ city

Baltimore

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Infrastructure

Revenue model

1. Donations and Philanthropy: Primary revenue stream through individual donations (one-time, monthly Brain Trust program, stock gifts), donor-advised funds, legacy/planned giving, and tribute gifts. Tax-exempt nonprofit organization.
2. Research Grants and Government Funding: Collaborative research funding from government sources including NIH and National Science Foundation, including notable US-China research collaborations.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

The Lieber Institute for Brain Development operates the world's largest postmortem brain repository dedicated to psychiatric research (nearly 5,000 human brains with paired clinical data, cell lines, and molecular samples) and a genes-to-drugs discovery pipeline that integrates medicinal chemistry, assay development, and in vivo pharmacology. The institute translates genetic and molecular insights on schizophrenia and related developmental brain disorders into novel therapeutic targets, biomarkers, and potential treatments.

Product overview

The Lieber Institute for Brain Development (LIBD) is an independent, nonprofit 501(c)(3) brain research and drug discovery institute offering a portfolio of research resources and programs rather than commercial products. The core offerings include the Brain Repository (nearly 5,000 postmortem brains, the largest collection worldwide for psychiatric research) and a Drug Discovery Pipeline integrating medicinal chemistry, assay development, and in vivo pharmacology. Supporting programs include the African Ancestry Neuroscience Research Initiative, a Human Cell Lines Repository (1,000+ lines), and the Brain Donor Program. Public-facing engagement products include The Rose Window podcast series and the Lieber Notes monthly newsletter. The institute also operates the Brain Trust monthly giving program for donor engagement.

Differentiator

Problem solved

Functional benefit

Brands

• Brain Trust: Monthly giving program where supporters become part of a community of committed donors helping scientists uncover the root causes of mental illness

Products and services

• Human Brain Repository The world's largest collection of postmortem human brains dedicated to psychiatric research, with nearly 5,000 specimens, detailed clinical and demographic classifications, tissue, blood, patient-derived cell lines, RNA and DNA samples, and quality control data including postmortem interval, RNA integrity number, pH, and toxicology. Used by academic and clinical researchers studying neuropsychiatric disorders.
• Human Cell Lines Repository A collection of 1,000+ human cell lines generated from clinical samples and postmortem brains, including lines from ~500 extensively studied individuals and over 500 individuals whose brains are also in the LIBD repository, made available to researchers for neuropsychiatric studies.
• Drug Discovery Pipeline A genes-to-drugs program integrating medicinal chemistry, assay development, and in vivo pharmacology with pharmacokinetics to identify and develop novel therapeutic molecules for psychiatric diseases, with four potential treatment options currently being tested.
• Brain Donor Program A program enabling families to donate their loved one's brain tissue for mental health research, feeding the LIBD brain repository with approximately 300+ family donations per year to support psychiatric research.
• African Ancestry Neuroscience Research Initiative (AANRI) A multi-institutional program addressing health disparities in neuroscience by increasing representation of African ancestry populations in brain research (<5% of current participants are Black), with pillars including community engagement, researcher development, and equitable research practices.
• The Rose Window Podcast A six-episode podcast series hosted by Dr. Daniel Weinberger with Ryan Cummins discussing the science of mental health and brain research, distributed on Apple Podcasts and Spotify as a donor and community engagement offering.

Quantifiable outcome

• Nearly 5,000 human brains donated for research enabling unprecedented psychiatric disorder studies
• +4 more outcomes

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Five partnerships are on record, tiered core, strategic and minor.

• Sheppard Pratt HospitalcoreStrategic or Co-development PartnerSheppard Pratt-Lieber Research Institute partnership: Sheppard Pratt is the largest neuropsychiatric clinical care program in the Mid-Atlantic States, treating 70,000 patients/year. Collaborative clinical research includes studies on Traumatic Brain Injury (TBI), Mild Cognitive Impairment (MCI), and Adult Autism. This translational clinical extension brings research from bench to bedside.
• Peking UniversitycoreStrategic or Co-development PartnerPeking University-Lieber Translational Neuropsychiatry Research Institute: A multi-year formal collaboration with China's leading research university. Includes the largest combined NIH, National Science Foundation of China award for US-Chinese medical research to-date. Gene x environment study of brain development has evaluated over 900 subjects.
• Johns Hopkins University School of MedicinecoreStrategic or Co-development PartnerAffiliated with Johns Hopkins University School of Medicine. Located on the Johns Hopkins Medical Campus with 48,000 sq ft of state-of-the-art laboratory space. LIBD is the largest non-Johns Hopkins University employer in the East Baltimore inner-city development project.
• African Ancestry Neuroscience Research Initiative (AANRI) PartnersstrategicStrategic or Co-development PartnerMulti-institutional initiative addressing health disparities in neuroscience research. Partners include academic institutions and community organizations working to increase representation of African ancestry populations in brain research (less than 5% of brain research participants are Black). Focuses on pillars of community engagement, researcher development, and equitable research practices.
• Icahn School of Medicine at Mount SinaiminorStrategic or Co-development PartnerResearch collaboration on Down syndrome study led by scientists at Icahn School of Medicine at Mount Sinai and Johns Hopkins University examining fetal brain tissue from individuals with Down syndrome.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Market position

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/@lieberinstitute
• Facebookfacebook.com/LieberInstitute
• LinkedInlinkedin.com/company/lieber-institute-for-brain-development
• Instagraminstagram.com/lieberinstitute
• Xx.com/lieberinstitute

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Lieber Institute for Brain Development